We performed spectral flow cytometry on side scatterloCD45dimCD33+ cells from patients with AML with TP53/TET2 comutations (n = 12), TET2 single mutations (n = 9), TP53 single mutations (n = 7), or WT TP53/TET2 (n = 7), separately. This evidence concerns the gene TET2 and acute myeloid leukemia.